MedPage Today on MSN

Are Bayesian Statistics Coming to a Clinical Trial Near You?

What physicians should know about FDA's new proposed guidance ...

Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

RAD 101 and evaluable at interim analysis achieved concordance with MRI imaging (the primary endpoint) First five patients with available data from six-month follow-up and biopsy show encouraging ...

Spear Bio Introduces New Ultra-Sensitive Neurodegenerative Assays and Expands Direct Access at AD/PD 2026

Spear Bio, an innovator in ultrasensitive protein biomarker detection, showcased three new SPEAR UltraDetect™ ...
Medycyna Praktyczna

Fibrosis-4 index screening beyond hepatology: a signal of systemic vulnerability

The Fibrosis-4 (FIB-4) index, computed from age, aspartate aminotrasfertase (AST) and alanine aminotransferase (ALT) levels, and platelet count, was originally developed in 832 pa ...